Case Study
HCP Disease Awareness Campaign
CIN Risk
Situation
Chemotherapy-induced neutropenia (CIN) is a major problem for patients in chemotherapy. The dangers of CIN are so severe, oncologists are often forced to decrease or delay chemotherapy treatment, even with the use of prophylactic G-CSFs.
Many oncologists feel that CIN is an inevitable part of chemotherapy and can manage neutropenia when it occurs.
The advent of COVID-19 has made the situation even more dangerous, as it places patients at increased risk of infection, hospitalization due to febrile neutropenia, and life-threatening events.
Immuno-marketing solution
Proximyl Health created a campaign so powerful and arresting that it simply could not be ignored.
The visuals in the campaign were designed to shake physicians from their complacency and further expose them to the dangers of CIN.
The campaign was also designed to educate oncologists around the unmet need in CIN, especially during the first cycle of chemotherapy.
Results
impressions from paid media
social media engagements
users on the website
and virtual booth